Physician profile
Madison Eldred
NPI 1801508593
$3,628.52
in general payments reported to CMS, 2019-2025
18 companies · $1,237 in 2025
The $1,237 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.98 · 2023: $216 · 2024: $2,137 · 2025: $1,237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,102 · Consulting Fee: $1,063 · Education: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,101.99 |
| Consulting Fee | $1,062.50 |
| Education | $425.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,566.77 | 2022-2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $400.92 | 2024-2025 | Sotyktu |
| Genzyme Corporation | $340.03 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $307.77 | 2023-2025 | Ilumya |
| Abbvie INC. | $214.39 | 2023-2025 | |
| Ucb, INC. | $147.69 | 2023-2025 | Bimzelx, Cimzia |
| Amgen INC. | $130.82 | 2023-2025 | Otezla, Otezla |
| Arcutis Biotherapeutics, INC. | $101.71 | 2024-2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $79.99 | 2024 | |
| Galderma Laboratories, L.P. | $79.20 | 2025 | Nemluvio |
| Genentech USA, INC. | $76.41 | 2024-2025 | Xolair |
| Lilly USA, LLC | $46.71 | 2023 | Taltz, Olumiant |
| Incyte Corporation | $43.72 | 2025 | Opzelura |
| Strata Skin Sciences, INC. | $26.16 | 2024 | Xtrac |
| Fresenius Kabi USA, LLC | $24.46 | 2024 | Idacio |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $14.83 | 2025 | Vtama |
| Leo Pharma INC. | $13.77 | 2023 | Adbry |
| Janssen Pharmaceuticals, INC | $13.17 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Eldred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.